Copyright © Inderes 2011 - present. All rights reserved.

Scibase Holding

0.38

 

SEK

 

-4.76 %

Less than 1K followers

SCIB

First North Stockholm

Medical Equipment & Services

Health Care

-4.76%
-0.26%
-1.55%
-7.32%
-2.56%
+18.75%
-90.9%
-82.52%
-98.65%

SciBase Holding is a global medical technology group specialized in diagnostics and prevention in dermatology. The company develops, produces and commercializes Nevisense, a patient-centered platform that combines AI (artificial intelligence) with EIS technology to enable early detection and intervention of skin cancer and other skin diseases. Nevisense is based on over 20 years of research at Karolinska Institutet, the headquarters are in Stockholm.

Read more
Market cap
128.55M SEK
Turnover
17.86K SEK
Revenue
29.71M
EBIT %
-226.09 %
P/E
-
Dividend yield-%
-
Latest research

Latest analysis report

Released: 2024-12-02

Latest extensive report

Released: 2024-02-01

Financial calendar
19/8
2025

Interim report Q2'25

7/11
2025

Interim report Q3'25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
Had a conversation with @Antti_Luiro in light of our recent report! Inderes SciBase: Capital raise explained - Inderes The ongoing capital raise would reduce the financing risks and secures SciBase's financing until early 2025. We expect the raise to succeed. Why? Analyst Antti Luiro...
4/22/2024, 1:55 PM
by Sara Antonacci
5
Mikael Maijala intervjuade Antti Luiro om SciBase i dag SciBase Q3’24: Waiting for the clear waters
11/14/2024, 1:34 PM
by Pia Maljanen
4
Ny analytikerintervju ute med @Antti_Luiro! Frågor? Funderingar kring SciBase? Antti finns alltid tillgänglig här för era frågor och tankar, så fritt fram! Inderes SciBase Q1´24: Building faster growth takes time - Inderes Time: 2024-06-05 12:00 In this interview you can hear our...
6/5/2024, 10:06 AM
by Jesper Hagman
4
SciBase har ingått ett partnerskap med den italienska distributören Kilabs för att underlätta inträdet på den italienska marknaden genom att utnyttja Kilabs lokala distributionsexpertis. SciBase anpassar sin Nevisense-teknologi för att uppfylla italienska regler, och lansering planeras...
10/30/2024, 7:35 PM
by börsen84
3
Kortkommentarer på SciBase angående aktuella nyheter och förändringar + kommande stegen framöver för bolaget.
8/23/2024, 12:52 PM
by Isa Hudd
3
SciBase on TV in the US: NBC Los Angeles Mole or skin cancer? A new device is making detection easier than ever &... California Live’s Jessica Vilchis closes out Skin Cancer Awareness Month with dermatologist Dr. Glynis Ablon to talk about startling statistics about America’s most...
5/31/2024, 10:44 AM
by Antti Luiro
3
SciBase har ingått ett samarbete med Seraly Dermatology i Pittsburgh. Kunden kommer att integrera flera Nevisense-system i processen för att upptäcka hudcancer. Seraly Dermatology verkar vara en liten aktör, men varje ny kund stärker Nevisense-produktens goda marknadsposition. Inderes...
9/27/2024, 5:00 AM
by börsen84
2
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.